Table 4.

36-Month Outcomes by Pretransplantation Disease Status

Pretransplant Disease Status	OS (95% CI)	PFS (95% CI)	NRM (95% CI)
CR1 (n 5 164)	64% (56–72)	54% (45–61)	18% (12–25)
≥CR2 (n 5 102)	58% (47–67)	54% (44–63)	27% (19–38)
CR1p (n 5 48)	45% (30–59)	38% (24–52)	30% (19–47)
≥CR2p (n 5 30)	31% (15–49)	32% (16–50)	24% (13–46)

OS indicates overall survival; PFS, progression-free survival; NRM, nonrelapse mortality; CR1, first complete remission; ≥CR2, equal to or greater than second complete remission; CR1p, CR1 without platelet recovery; and≥CR2p, equal to or greater than second complete remission without platelet recovery.